Dr. Faustman is an elected fellow of the American Association for the Advancement of Science and of the Society for Risk Analysis. She has also been involved in several National Research Council committees, including the Committee on Spacecraft Exposure Guidelines, the Committee on Developmental Toxicology, and the Committee on Toxicology. Dr. Faustman received a PhD in toxicology from Michigan State University.

Lynn R. Goldman, a pediatrician and epidemiologist, is a professor at the Johns Hopkins University Bloomberg School of Public Health, where she focuses on environmental health policy, public-health practice, and children’s environmental health. Dr. Goldman previously served as the assistant administrator for the U.S. Environmental Protection Agency (EPA) Office of Prevention, Pesticides and Toxic Substances. During her tenure at EPA, Dr. Goldman was responsible for the nation’s pesticide, toxic-substances, and pollution-prevention laws, and she was successful in promoting children’s health issues and furthering the international agenda for global chemical safety. Before joining EPA, Dr. Goldman served in several positions in the California Department of Health Services, most recently as head of the Division of Environmental and Occupational Disease Control. She has served on numerous boards and expert committees, including the Committee on Environmental Health of the American Academy of Pediatrics and the Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention. She has also served as a member of numerous National Research Council (NRC) committees, including the Committee on Identifying and Assessing Unintended Effects of Genetically Engineered Foods on Human Health, the Committee on Clinical Trial Registries, and the Committee to Evaluate the Hazardous Materials Management Program of the Bureau of Land Management. She is vice chair of the Institute of Medicine (IOM) Roundtable on Environmental Health Sciences, chair of the IOM Committee on Secondhand Smoke Exposure and Acute Coronary Events, and a member of the NRC Standing Committee on Risk Analysis Issues and Reviews. Dr. Goldman received her MD from the University of California, San Francisco.

Michael Lawton is an associate research fellow and head of the Molecular Toxicology Group at Pfizer in Groton, CT. His molecular-toxicology laboratory applies molecular approaches in support of predictive toxicology, identifies molecular biomarkers, and investigates mechanistic toxicology for early- and late-stage safety assessment. Dr. Lawton participates in the Vascular Injury Working Group of the external Predicative Safety Testing Consortium and supports the Internal Hepatic and Vascular Injury Project teams. He is also the principal investigator for several external technology collaborations. He is a member of the Society of Toxicology and councilor of its Drug Discovery Toxicology Specialty Section. Dr. Lawton received a PhD in toxicology from North Carolina State University.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement